title: Radiation therapy for endometrial cancer in patients treated for postoperative recurrence.
abstract: OBJECTIVE
  To retrospectively evaluate the outcome and risk factors in patients treated with radiation for endometrial cancer at time of recurrence.
  
  
  METHODS
  Three hundred ninety-nine women were treated with radiation therapy for endometrial cancer at KCI/WSU from January 1980 to December 1994. Of these, 26 patients treated primarily with surgery received radiation therapy at the time of recurrence. Median time to recurrence after surgery was 8 months, with all recurrences occurring within 24 months. Twenty-four patients had recurrences in the vaginal cuff, vagina, or pelvis. These patients received external-beam radiation to the pelvis (45.00-50.40 Gy) and periaortic lymph nodes (45.00-50.00 Gy), along with a boost given by external-beam radiation or brachytherapy (16.00-30.00 Gy). Mean follow-up was 15 months (range 1-85 months).
  
  
  RESULTS
  The 2-year survival was 50% and median survival was 16 months (survival range 1-85 months). Of 26 patients, 54% (14) failed locally following radiation therapy. Factors indicative of poor survival included histology (sarcoma, poorly differentiated adenocarcinoma), grade, and lymph node positivity. Histological differentiation influenced local control; lymphovascular space invasion was of borderline significance with regard to local control.
  
  
  CONCLUSIONS
  Local control and survival for surgically treated endometrial cancer patients who receive radiation at the time of recurrence are poor, with the exception of those patients with recurrent disease limited to the vagina. Early detection of recurrence may improve outcome. Pathologic risk factors may identify those patients at risk for extrapelvic recurrence. Alternative treatment modalities need to be developed for this high-risk group of patients.
authors.affiliation: Department of Radiation Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.
authors.forename: K B
authors.initials: KB
authors.lastname: Hart
authors.forename: I
authors.initials: I
authors.lastname: Han
authors.forename: F
authors.initials: F
authors.lastname: Shamsa
authors.forename: W S
authors.initials: WS
authors.lastname: Court
authors.forename: P
authors.initials: P
authors.lastname: Chuba
authors.forename: G
authors.initials: G
authors.lastname: Deppe
authors.forename: J
authors.initials: J
authors.lastname: Malone
authors.forename: C
authors.initials: C
authors.lastname: Christensen
authors.forename: A T
authors.initials: AT
authors.lastname: Porter
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016889:Endometrial Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014625:Vaginal Neoplasms / Q000532:radiotherapy* / Q000556:secondary